191 related articles for article (PubMed ID: 17612054)
1. NSAIDs for the chemoprevention of Alzheimer's disease.
Szekely CA; Town T; Zandi PP
Subcell Biochem; 2007; 42():229-48. PubMed ID: 17612054
[TBL] [Abstract][Full Text] [Related]
2. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
3. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis.
Wang J; Tan L; Wang HF; Tan CC; Meng XF; Wang C; Tang SW; Yu JT
J Alzheimers Dis; 2015; 44(2):385-96. PubMed ID: 25227314
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
Hirohata M; Ono K; Yamada M
Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
[TBL] [Abstract][Full Text] [Related]
6. Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.
Deardorff WJ; Grossberg GT
Expert Rev Neurother; 2017 Jan; 17(1):17-32. PubMed ID: 27293026
[TBL] [Abstract][Full Text] [Related]
7. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence.
Launer L
Drugs; 2003; 63(8):731-9. PubMed ID: 12662122
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.
Cole GM; Frautschy SA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):140-8. PubMed ID: 20205646
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of NSAIDs on the development of Alzheimer disease.
Vlad SC; Miller DR; Kowall NW; Felson DT
Neurology; 2008 May; 70(19):1672-7. PubMed ID: 18458226
[TBL] [Abstract][Full Text] [Related]
12. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
13. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
15. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
16. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
Szekely CA; Green RC; Breitner JC; Østbye T; Beiser AS; Corrada MM; Dodge HH; Ganguli M; Kawas CH; Kuller LH; Psaty BM; Resnick SM; Wolf PA; Zonderman AB; Welsh-Bohmer KA; Zandi PP
Neurology; 2008 Jun; 70(24):2291-8. PubMed ID: 18509093
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
18. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
19. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
Weggen S; Rogers M; Eriksen J
Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.
Prasad KN; Cole WC; Prasad KC
J Am Coll Nutr; 2002 Dec; 21(6):506-22. PubMed ID: 12480796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
